Wolverine Asset Management LLC Seagen Inc. Transaction History

Wolverine Asset Management LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 13, 2023	SELL	$191.51 - $216.16 $38,302 - $43,232	-200 Reduced 1.06%	18,635 $3.95 Million
Q2 2023 Aug 07, 2023	BUY	$187.64 - $206.25 $1.51 Million - $1.66 Million	8,060 Added 74.8%	18,835 $3.62 Million
Q1 2023 May 08, 2023	BUY	$127.59 - $203.08 $1.37 Million - $2.19 Million	10,775 New	10,775 $2.18 Million
Q1 2021 May 13, 2021	SELL	$137.51 - $190.8 $1,237 - $1,717	-9 Closed	0 $0
Q4 2020 Feb 12, 2021	BUY	$164.63 - $211.93 $1,481 - $1,907	9 New	9 $1,000

1.26M

23K

55.2K

Ticker SGEN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 185,664,992
Description
Seagen Inc., a biotechnology company, develops and commercializes therapies for the treatment of cancer in the United States and internationally. The company offers ADCETRIS, an antibody-drug conjugate (ADC) for the treatment of patients with Hodgkin lymphoma or CD30-positive T-cell lymphomas; PADCEV, an ADC targeting Nectin-4 for the treatment ...

Get notified when there are updates to the investment portfolio of Wolverine Asset Management LLC, based on Form 13F filings with the SEC.

Stay updated on Wolverine Asset Management LLC with notifications on news.